
51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
Biotechnology • Pharmaceuticals
BBOT is a biotechnology company developing targeted therapies for cancers driven by RAS signaling and PI3Kα. The company focuses on rational drug design to inhibit the active ON state of RAS and to selectively block RAS-driven PI3K activation, aiming at multiple KRAS mutants and novel approaches to maximize target inhibition. BBOT translates decades of RAS biology research into therapeutic candidates intended to improve outcomes for patients with RAS- and PI3Kα-driven tumors.
🔥 4 hours ago
Director of Medical Writing responsible for strategic leadership and document delivery at BridgeBio Oncology Therapeutics. Leading complex regulatory submissions with a focus on oncology therapeutics.
🕒 July 3
Director or Senior Director providing scientific and strategic leadership across oncology pipeline at BridgeBio. Overseeing clinical pharmacology strategy and collaborating with cross-functional teams.
🕒 July 3
Clinical Trial Manager overseeing execution of oncology clinical trials for BridgeBio Oncology Therapeutics. Focused on ensuring adherence to timelines, budgets, and quality standards.
🕒 June 23
Senior Medical Director overseeing clinical studies and leading cross-functional teams at Bridge Bio Oncology Therapeutics. Ensuring compliance with ethical and regulatory requirements while improving patient lives.
🕒 February 25
Toxicologist leading non-clinical toxicology activities for drug development at a biotech company. Collaborating with cross-functional teams and providing strategic oversight for multiple oncology programs.
🗣️🇨🇳 Chinese Required